title: Pfizer-Allergan deal could reduce biosimilar cost savings.
authors.forename: Steven Ross
authors.initials: SR
authors.lastname: Johnson
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000191:economics*; D003299:Cooperative Behavior; D017046:Cost Savings; D004345:Drug Industry; D019982:Organizational Case Studies; D014481:United States
chemical_list: D059451:Biosimilar Pharmaceuticals